Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Karen Moreland

Physician Assistant Fort Worth, TX Physician Assistant

NPI 1013204007 CMS profile 10833913

6600 Bryant Irvin Rd, Fort Worth, TX 76132

Open in the dashboard

General payments

$10,352

425 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Karen Moreland of Fort Worth, TX is reported in the CMS Open Payments database as having received $10,352 across 425 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,992 74
2024 General $2,525 94
2023 General $2,173 97
2022 General $2,314 107
2021 General $1,348 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Karen Moreland
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Karen Moreland were reported at $1,992. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Karen Moreland Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,348 $132 $37–$438 $132
2022 $2,314 $155 $48–$522 $149
2023 $2,173 $167 $52–$557 $160
2024 $2,525 $178 $55–$600 $164
2025 $1,992 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,684 58 payments
  2. Genzyme Corporation $1,233 37 payments
  3. Novartis Pharmaceuticals Corporation $1,191 53 payments
  4. Dermavant Sciences, Inc. $755 34 payments
  5. Galderma Laboratories, L.P. $741 25 payments
  6. Lilly USA, LLC $676 22 payments
  7. Janssen Biotech, Inc. $630 41 payments
  8. UCB, Inc. $526 21 payments
  9. E.R. Squibb & Sons, L.L.C. $427 15 payments
  10. Mayne Pharma Inc. $334 24 payments
  11. Other $2,155 95 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $10,263 423 payments
  2. Education $88 2 payments
Products named General payments · program years 2021–2025
  1. DUPIXENT $1,705 50 payments
  2. SKYRIZI $992 32 payments
  3. VTAMA $797 37 payments
  4. COSENTYX Dermatology $621 27 payments
  5. TALTZ $557 21 payments
  6. TREMFYA $548 36 payments
  7. COSENTYX Immunology $530 24 payments
  8. OLUMIANT $438 14 payments
  9. Bimzelx $433 16 payments
  10. SOTYKTU $427 15 payments
  11. Other $3,840 178 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

425 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record